The growing trend of vaping 5MeO dimethyltryptamine in Canada presents significant hazards and complicated juridical issues. Currently, 5MeO dimethyltryptamine remains a Schedule I substance within the CDSA, making its holding and sale illegal. While ingestion delivers the compound quickly, it also introduces additional medical risks linked with e-